Paris, France

Carole Bloquel



 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carole Bloquel: Innovator in Ocular Therapeutics

Introduction

Carole Bloquel is a prominent inventor based in Paris, France. She has made significant contributions to the field of ocular therapeutics, particularly through her innovative methods and devices for delivering therapeutic products to the ocular sphere. Her work focuses on improving the administration of biologically active agents, especially in gene therapy applications.

Latest Patents

Carole Bloquel holds 1 patent for her invention titled "Methods and devices for delivering a therapeutic product to the ocular sphere of a subject." This invention relates to enhanced methods for delivering therapeutic or prophylactic nucleic acids to the ocular sphere. It specifically involves administering these agents to ciliary body tissues or extra-ocular muscle tissues. The invention also encompasses devices and pharmaceutical compositions designed for effective treatment of ocular pathologies.

Career Highlights

Throughout her career, Carole has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and Inserm. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in ocular therapeutics.

Collaborations

Carole has collaborated with notable colleagues, including Francine Behar-Cohen and David Benezra. These partnerships have further enriched her research and development efforts in the field of ocular medicine.

Conclusion

Carole Bloquel's innovative work in ocular therapeutics exemplifies her commitment to advancing medical science. Her contributions through patents and collaborations continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…